French pharmaceutical manufacturer Synerlab has acquired Spanish contract development and manufacturing organization (CDMO) Alcala Farma. The group specializes in the development of proprietary formulations, which represent nearly 40% of its total €25m sales. Alcala Farma’s current portfolio of pharmaceutical drugs come in multiple dosage forms, including injectable, oral and topical products. Manufacturing is covered by two production sites in Spain, with one specializing in soft gelat...